These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 10500822)
1. MTT assay for drug resistance in childhood acute leukemia and effect of cyclosporin and interferon. A preliminary report. Karakaş Z; Ağaoğlu L; Erdem S; Anak S; Hacibektaşoğlu A; Gedikoğlu G Adv Exp Med Biol; 1999; 457():453-9. PubMed ID: 10500822 [No Abstract] [Full Text] [Related]
2. Cellular drug resistance in childhood acute myeloid leukemia. A mini-review with emphasis on cell culture assays. Kaspers GJ; Zwaan CM; Pieters R; Veerman AJ Adv Exp Med Biol; 1999; 457():415-21. PubMed ID: 10500817 [TBL] [Abstract][Full Text] [Related]
3. Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test. Hwang WS; Chen LM; Huang SH; Wang CC; Tseng MT Leuk Res; 1993 Aug; 17(8):685-8. PubMed ID: 8355513 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of blast cell sensitivity to low-intensity laser radiation and chemotherapeutic drugs]. Karu TI; Riabykh TP; Sidorova TA; Dobrynin IaV Dokl Akad Nauk; 1997 Mar; 353(1):114-7. PubMed ID: 9273047 [No Abstract] [Full Text] [Related]
5. Is in vitro sensitivity of blast cells correlated to therapeutic effect in childhood acute lymphoblastic leukemia? Frost BM; Larsson R; Nygren P; Lönnerholm G Adv Exp Med Biol; 1999; 457():423-8. PubMed ID: 10500818 [TBL] [Abstract][Full Text] [Related]
6. Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias. Kravtsov VD; Greer JP; Whitlock JA; Koury MJ Blood; 1998 Aug; 92(3):968-80. PubMed ID: 9680366 [TBL] [Abstract][Full Text] [Related]
7. Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome? Frost BM; Gustafsson G; Larsson R; Nygren P; Lönnerholm G Leukemia; 2000 May; 14(5):943-4. PubMed ID: 10803530 [No Abstract] [Full Text] [Related]
8. Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia. Pieters R; Huismans DR; Leyva A; Veerman AJ Br J Cancer; 1989 Feb; 59(2):217-20. PubMed ID: 2930687 [No Abstract] [Full Text] [Related]
9. Prognosis in adult AML is precisely predicted by the DISC-assay using the chemosensitivity-index Ci. Staib P; Lathan B; Schinköthe T; Wiedenmann S; Pantke B; Dimski T; Voliotis D; Diehl V Adv Exp Med Biol; 1999; 457():437-44. PubMed ID: 10500820 [TBL] [Abstract][Full Text] [Related]
10. Circumvention of glucocorticoid resistance in childhood leukemia. Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253 [TBL] [Abstract][Full Text] [Related]
11. [Natural killer activity--an index of the efficacy of the treatment of patients with acute leukemia]. Gashchuk AP; Evtukh VP; Kindzel'skiĭ AL Lik Sprava; 1994; (5-6):79-81. PubMed ID: 7831919 [No Abstract] [Full Text] [Related]
12. A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia. Wartman LD; Fiala MA; Fletcher T; Hawkins ER; Cashen A; DiPersio JF; Jacoby MA; Stockerl-Goldstein KE; Pusic I; Uy GL; Westervelt P; Vij R Leuk Lymphoma; 2016; 57(3):728-30. PubMed ID: 26674111 [No Abstract] [Full Text] [Related]
13. A novel chemosensitivity profiling platform for small acute lymphoblastic leukemia cell populations. Groth-Pedersen L; Chen YH; Faber M; Valentin R; Albertsen BK; Wehner PS; Rosthøj S; Frandsen TL; Marquart HV; Schmiegelow K Leuk Lymphoma; 2015 Jul; 56(7):2208-11. PubMed ID: 25530346 [No Abstract] [Full Text] [Related]
14. In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. Kaspers GJ; Pieters R; Van Zantwijk CH; De Laat PA; De Waal FC; Van Wering ER; Veerman AJ Br J Cancer; 1991 Sep; 64(3):469-74. PubMed ID: 1911186 [TBL] [Abstract][Full Text] [Related]
15. Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report. Kaspers GJ; Kardos G; Pieters R; Van Zantwijk CH; Klumper E; Hählen K; de Waal FC; van Wering ER; Veerman AJ Leukemia; 1994 Jul; 8(7):1224-9. PubMed ID: 8035616 [TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report. Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861 [No Abstract] [Full Text] [Related]
17. Targeting the bone marrow microenvironment in acute leukemia. Karantanou C; Godavarthy PS; Krause DS Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560 [TBL] [Abstract][Full Text] [Related]
18. Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia. Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ Recent Results Cancer Res; 1993; 131():249-56. PubMed ID: 8210644 [No Abstract] [Full Text] [Related]
19. Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia. Styczynski J; Piatkowska M; Jaworska-Posadzy A; Czyzewski K; Kubicka M; Kolodziej B; Kurylo-Rafinska B; Debski R; Pogorzala M; Wysocki M Anticancer Res; 2012 Dec; 32(12):5495-9. PubMed ID: 23225457 [TBL] [Abstract][Full Text] [Related]
20. Drug resistance testing of acute myeloid leukemia in adults using the MTT assay. Stute N; Köhler T; Lehmann L; Wetzstein W; Ehninger G Adv Exp Med Biol; 1999; 457():445-52. PubMed ID: 10500821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]